Most people on Ozempic lose between 5% and 15% of their body weight, depending on the dose, how long they take it, and whether they’re using it for diabetes or weight management. For someone weighing 220 pounds, that translates to roughly 11 to 33 pounds. The wide range reflects real differences in how individuals respond, but clinical trials give us solid benchmarks at each stage of treatment.
What the Clinical Trials Show
The clearest data comes from the STEP 1 trial, which tested a weekly 2.4 mg dose of semaglutide (the active ingredient in Ozempic, marketed at that higher dose as Wegovy) in adults without diabetes. After 68 weeks, participants lost an average of 14.9% of their body weight, compared to just 2.4% in the placebo group. For a 220-pound person, that’s about 33 pounds lost from the drug itself, beyond what diet and exercise alone achieved.
Ozempic is FDA-approved for type 2 diabetes at lower doses (up to 2 mg), and weight loss at those doses is more modest. In the SUSTAIN FORTE trial, which compared the 1 mg and 2 mg doses in people with type 2 diabetes, average weight loss over 40 weeks ranged from about 9 to 14 pounds. That’s less dramatic than the STEP trial results, partly because the dose is lower and partly because people with diabetes often have metabolic factors that make weight loss harder.
A Realistic Timeline
Weight loss on Ozempic doesn’t happen all at once. The dose starts low and ramps up over several weeks to minimize side effects, so early results are gradual. Here’s what clinical data shows at each stage:
- First month: About 2% of body weight, or roughly 4 to 5 pounds for someone starting at 220 pounds. This phase is mostly about adjusting to the medication.
- Months 2 to 3: Weight loss picks up, reaching 4% to 6% of body weight. A study of adults without diabetes found an average of 6.3% lost after three months.
- Months 3 to 6: Results from the STEP trials show 6% to 10% body weight reduction by this point. This is when many people notice visible changes.
- Months 6 to 16: Weight loss continues but slows, eventually reaching a plateau. The 14.9% average from the STEP 1 trial came at the 68-week mark (about 16 months).
Most of the weight comes off in the first 6 to 9 months. After that, the curve flattens and the medication’s role shifts more toward maintaining what you’ve lost.
How Ozempic Causes Weight Loss
Semaglutide mimics a gut hormone called GLP-1 that your body naturally produces after eating. This hormone does two things that directly reduce how much you eat. First, it activates receptors in the brain that control hunger and fullness, dialing down appetite so you feel satisfied with less food. Second, it slows the rate at which food leaves your stomach, so meals keep you full for longer.
The combined effect is a significant drop in calorie intake without the constant willpower battle that makes most diets fail. People on semaglutide consistently report less food noise, fewer cravings, and a genuine indifference to portions that would have tempted them before. The drug doesn’t speed up your metabolism. It works almost entirely by changing how hungry you feel.
Why Results Vary So Much
Not everyone loses the same amount. Some people drop 20% of their body weight; others lose 5% or less on the same dose. Several factors influence where you land on that spectrum.
Body composition matters. Research published in 2025 found that people with higher metabolic rates and greater skeletal muscle mass, particularly in the abdomen and limbs, had better odds of significant weight loss on GLP-1 drugs. This makes sense: more muscle means a higher baseline calorie burn, so even a modest reduction in food intake creates a larger deficit.
Dose plays an obvious role. The 2.4 mg weekly dose used in weight management trials produces roughly double the weight loss of the 1 mg diabetes dose. Diet and exercise amplify results at any dose. The clinical trials paired medication with lifestyle counseling, and real-world outcomes tend to be slightly lower when that structure isn’t there. Starting weight, age, and whether you have insulin resistance or type 2 diabetes also shift the numbers, generally making weight loss somewhat slower for people managing diabetes.
What Happens If You Stop
This is the part most people don’t hear about upfront. A 2025 systematic review in The BMJ found that people regain an average of 6 kg (about 13 pounds) within the first year of stopping incretin-based drugs like semaglutide. For newer, more effective versions of these drugs, the projected regain was even steeper: about 10 kg (22 pounds) in the first year. The analysis estimated a full return to baseline weight within roughly 1.5 years of stopping treatment.
This doesn’t mean the medication “didn’t work.” It means semaglutide manages appetite the way blood pressure medication manages blood pressure. The underlying biology reasserts itself when the drug is removed. For most people, sustaining the weight loss means either continuing the medication long-term or making substantial, permanent changes to eating and activity patterns during treatment that can partially offset regain.
Ozempic vs. Wegovy for Weight Loss
Ozempic and Wegovy contain the same drug, semaglutide, made by the same company. The difference is the approved use and maximum dose. Ozempic tops out at 2 mg per week and is prescribed for type 2 diabetes. Wegovy goes up to 2.4 mg and is approved specifically for weight management. Many of the headline weight loss numbers people see online come from Wegovy-dose trials, so if you’re on Ozempic at 0.5 mg or 1 mg for diabetes, expecting a 15% drop in body weight isn’t realistic. A more likely range at those doses is 5% to 8% over several months, with some people exceeding that.
Doctors sometimes prescribe Ozempic off-label for weight loss when Wegovy is unavailable or not covered by insurance. The results depend heavily on which dose you can tolerate and maintain. If your provider titrates you up to the full 2 mg dose, your results will be closer to, though still slightly below, the Wegovy trial numbers.